Ambev (NYSE:ABEV) Releases Quarterly Earnings Results, Meets Estimates

Ambev (NYSE:ABEV) issued its earnings results on Wednesday. The company reported $0.04 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.04, FiscalAI reports. The business had revenue of $3.89 billion during the quarter, compared to analysts’ expectations of $4.05 billion. Ambev had a net margin of 17.69% and a return on equity of 16.63%.

Ambev Stock Performance

NYSE ABEV traded down $0.03 during trading on Friday, reaching $3.10. The company’s stock had a trading volume of 57,167,515 shares, compared to its average volume of 25,950,451. The company has a debt-to-equity ratio of 0.02, a quick ratio of 0.78 and a current ratio of 1.03. The firm has a market cap of $48.78 billion, a price-to-earnings ratio of 16.29, a P/E/G ratio of 1.81 and a beta of 0.64. Ambev has a twelve month low of $2.10 and a twelve month high of $3.45. The business’s fifty day moving average price is $3.13 and its 200-day moving average price is $3.03.

Ambev Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, January 11th. Shareholders of record on Wednesday, June 24th will be given a dividend of $0.0092 per share. This represents a $0.04 annualized dividend and a yield of 1.2%. The ex-dividend date of this dividend is Wednesday, June 24th. Ambev’s dividend payout ratio (DPR) is presently 10.53%.

Analyst Upgrades and Downgrades

Several equities analysts have issued reports on the stock. Scotiabank downgraded shares of Ambev from a “sector outperform” rating to a “sector perform” rating in a research note on Wednesday, July 15th. UBS Group lifted their target price on Ambev from $2.65 to $2.90 and gave the stock a “sell” rating in a research report on Thursday, May 14th. Barclays boosted their target price on Ambev from $3.00 to $3.50 and gave the company an “equal weight” rating in a report on Wednesday, May 6th. Wall Street Zen cut Ambev from a “buy” rating to a “hold” rating in a research report on Monday, July 13th. Finally, Weiss Ratings downgraded Ambev from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Wednesday, May 6th. Six investment analysts have rated the stock with a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, Ambev has an average rating of “Reduce” and a consensus price target of $3.09.

Insider Activity

In related news, insider Paulo Andre Zagman sold 136,250 shares of the business’s stock in a transaction dated Tuesday, May 5th. The stock was sold at an average price of $3.41, for a total value of $464,612.50. Following the transaction, the insider owned 230,535 shares in the company, valued at $786,124.35. The trade was a 37.15% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, Director Ricardo Manuel Frangat Moreira sold 468,040 shares of the business’s stock in a transaction dated Thursday, July 30th. The shares were sold at an average price of $3.08, for a total value of $1,441,563.20. Following the completion of the transaction, the director owned 3,000,000 shares in the company, valued at $9,240,000. This trade represents a 13.50% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure.

Institutional Trading of Ambev

A number of hedge funds have recently added to or reduced their stakes in the stock. Morgan Stanley increased its holdings in shares of Ambev by 291.2% in the fourth quarter. Morgan Stanley now owns 45,462,628 shares of the company’s stock valued at $112,293,000 after purchasing an additional 33,842,540 shares during the period. GQG Partners LLC grew its position in Ambev by 9.1% in the 4th quarter. GQG Partners LLC now owns 172,969,655 shares of the company’s stock valued at $427,235,000 after buying an additional 14,468,963 shares during the last quarter. Goldman Sachs Group Inc. increased its stake in Ambev by 248.1% in the 4th quarter. Goldman Sachs Group Inc. now owns 13,135,697 shares of the company’s stock valued at $32,445,000 after buying an additional 9,361,815 shares during the period. CANADA LIFE ASSURANCE Co raised its position in Ambev by 74.8% during the 2nd quarter. CANADA LIFE ASSURANCE Co now owns 13,409,316 shares of the company’s stock worth $32,624,000 after buying an additional 5,740,155 shares during the last quarter. Finally, Bank of America Corp DE lifted its stake in shares of Ambev by 9.9% in the 2nd quarter. Bank of America Corp DE now owns 27,505,192 shares of the company’s stock worth $66,288,000 after acquiring an additional 2,479,310 shares during the period. 8.13% of the stock is owned by institutional investors and hedge funds.

Trending Headlines about Ambev

Here are the key news stories impacting Ambev this week:

• Positive Sentiment: Ambev’s board approved approximately R$2.7 billion in interest-on-capital payments for 2026, including the third and final installment. The payout supports the stock’s income appeal and signals continued cash-return capacity. Ambev Approves R$2.7 Billion in Interest on Capital Payments for 2026
• Positive Sentiment: The brewer is preparing for hotter conditions associated with El Niño. Warmer weather could support demand for beer and other beverages, although the eventual effect will depend on regional weather patterns and operating costs. Ambev se prepara para clima mais quente com El Niño
• Neutral Sentiment: Barclays reaffirmed its Hold rating, indicating the analyst does not see a sufficiently compelling near-term catalyst to change its stance. Barclays Reaffirms Their Hold Rating on Ambev SA
• Neutral Sentiment: Ambev filed its July Form 6-K, reaffirming its U.S. reporting status. The filing is a routine compliance update with limited direct effect on valuation. Ambev July 2026 Form 6-K
• Negative Sentiment: Ambev’s latest results were mixed: adjusted EPS of $0.04 met consensus, but revenue of $3.89 billion fell short of the $4.05 billion estimate. The top-line miss is the clearest reason for investor pressure, suggesting weaker-than-expected sales momentum despite earnings execution. Ambev Q2 2026 Earnings Call Transcript

About Ambev

Ambev (NYSE: ABEV) is a Brazilian-based beverage company that produces, distributes and markets a broad portfolio of alcoholic and non-alcoholic drinks. The company’s core business centers on brewing and selling beer, alongside a range of soft drinks, bottled water, energy drinks and other malt-based beverages. Headquartered in São Paulo, Ambev operates an integrated value chain that covers manufacturing, packaging, logistics and commercial sales to retail, on-premise and institutional customers.

The company traces its origins to the 1999 merger of two historic Brazilian breweries, and later became part of the broader global brewing group through subsequent industry consolidations.